Uso de ácido ascórbico en pacientes con traumatismo craneoencefálico severo y su impacto en el tiempo de estancia en la Unidad de Cuidados Intensivos adultos

Introduction : Traumatic brain injury (TBI) is the leading cause of death and disability in young adults around the world. The secondary lesion develops with the release of oxygen free radicals. In addition to its powerful action as a free radical scavenger, ascorbic acid stabilizes the endothelium and promotes the integrity of the blood-brain barrier (BBB). Objective : To determine the usefulness of ascorbic acid in patients with severe TBI and its impact on the length of hospital stay in the Adult Intensive Care Unit (ICU). Material and methods : Randomized clinical trial, open in the ICU of the Centro Médico Nacional del Bajío UMAE No. 1, León, Guanajuato, Mexico, from April 2020 to July 2020. 24 patients (12 experimental group and 12 controls) were admitted by probabilistic sampling with Severe TBI in people over 18 years of age. Administration of ascorbic acid one gram every six hours intravenously. Ascorbic acid administration was correlated with length of stay in ICU and hospitalization, mortality and neurological scales. Analysis of SPSS version 21 results. Results : 24 patients were included, mean ages 26 and 49 years, experimental and control group respectively (p = 0.004). Average of the Glasgow Coma Scale at the time of admission was 7 and 6.7 points respectively (p = 0.378). Stay in the ICU with 7 and 3.71 days (p = 0.001), hospital stay 12.5 and 5.85 days respectively (p = 0.001). At discharge, the Glasgow scale resulted in 3.50 and 3.57 points respectively (p = 0.630). 28-day mortality of 1 and 3 cases respectively (p = 0.59); the survival analysis reflected higher survival for the experimental group (p = 0.010). Conclusion : The use of ascorbic acid in severe TBI had a negative impact on the ICU stay, as well as the length of hospitalization. Survival analysis showed lower mortality at 28 days for the experimental group compared to the control.

• Publication year

  2021

• Venue

  Medicina Crítica

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.35366/100002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• In Reply: Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy Recommendations.

  2020cited by this paper
• Trials

  2020cited by this paper
• Effects of ascorbic acid supplementation on oxidative stress markers in healthy women following a single bout of exercise

  2019cited by this paper
• WSES consensus conference guidelines: monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours

  2019cited by this paper
• High-Dose Intravenous Ascorbic Acid: Ready for Prime Time in Traumatic Brain Injury?

  2019cited by this paper
• Predictive utility of an adapted Marshall head CT classification scheme after traumatic brain injury

  2019cited by this paper
• Controversies in Severe Traumatic Brain Injury Management

  2018cited by this paper
• Severe traumatic brain injury: targeted management in the intensive care unit.

  2017cited by this paper
• Traumatic Brain Injury–Related Emergency Department Visits, Hospitalizations, and Deaths — United States, 2007 and 2013

  2017cited by this paper
• Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.

  2017cited by this paper
• Attenuation of Red Blood Cell Storage Lesions with Vitamin C

  2017cited by this paper
• Predictive Value of Glasgow Coma Score and Full Outline of Unresponsiveness Score on the Outcome of Multiple Trauma Patients.

  2016cited by this paper
• Oxalate Nephropathy After Continuous Infusion of High-Dose Vitamin C as an Adjunct to Burn Resuscitation

  2016cited by this paper
• The Glasgow Outcome Scale — 40 years of application and refinement

  2016cited by this paper
• Traumatic brain injury: pathophysiology for neurocritical care

  2016cited by this paper
• Cerebral Edema in Traumatic Brain Injury: Pathophysiology and Prospective Therapeutic Targets.

  2016cited by this paper
• Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in vivo Study

  2015cited by this paper
• Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain

  2015cited by this paper
• The Glasgow Coma Scale at 40 years: standing the test of time.

  2014cited by this paper
• Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

  2014cited by this paper
• Escala de coma de Glasgow: origen, análisis y uso apropiado

  2014cited by this paper
• Effects of α-tocopherol and ascorbic acid in the severity and management of traumatic brain injury in albino rats

  2013cited by this paper
• Vitamin C transport and its role in the central nervous system.

  2012cited by this paper
• The Handbook of Neuroprotection

  2011cited by this paper
• Administration of Vitamin C and Vitamin E in Severe Head Injury: A Randomized Double-blind Controlled Trial

  2011cited by this paper
• Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study

  2008cited by this paper
• Randomized, Prospective Trial of Antioxidant Supplementation in Critically Ill Surgical Patients

  2002cited by this paper
• Plasma Vitamin C Levels Are Decreased and Correlated With Brain Damage in Patients With Intracranial Hemorrhage or Head Trauma

  2001cited by this paper

• No citing papers are available for this paper.